Close
APE 2026

Boston Scientific launches Neuroform EZ Stent System

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Abbott to Acquire Cancer Test Maker...

In a recent move, Abbott has gone ahead and...

New Policy to Boost Medical Device...

Beijing has gone on to release a new policy...

US Lawmakers Push Access For AI-Powered...

The US bipartisan legislation, which was introduced in the...

Boston Scientific Corporation announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms.  The Company plans to launch the product immediately in both markets.

The Neuroform EZ Stent System is engineered to provide flexibility and conformability, especially in tortuous brain anatomy.  It employs Boston Scientific’s proprietary Segmental™ Expansion technology, designed to enhance stent anchoring and stability.  The product features the proven hybrid cell design of prior-generation Neuroform Stents while incorporating a simplified, single-operator delivery system intended to facilitate preparation, delivery and positioning of the stent. 

The first Neuroform EZ Stent was implanted in the U.S. by Demetrius Lopes, M.D., of the Rush University Medical Center in Chicago, and the first European procedure was performed by Professor Laurent Spelle, M.D., Ph.D., at Foundation Rothschild Hospital, Beaujon School of Medicine in Paris. 

"The Neuroform EZ Stent System performed well in a very challenging first procedure," said Dr. Lopes.  "The smooth transfer of the stent into the catheter, combined with excellent support, stability and visibility, facilitated accurate stent placement."

"The improved delivery system of the Neuroform EZ Stent helped me to place the stent exactly where I planned," said Professor Spelle.  "In my experience, Boston Scientific’s new system is easier to use compared to its previous microdelivery system and should offer benefits for both physicians and patients."

"Boston Scientific is pleased to offer this new technology, which is designed to help physicians simplify these complex neurovascular procedures," said Mark Paul, President of Boston Scientific’s Neurovascular Division.  "The Neuroform EZ Stent System reinforces our commitment to providing advanced treatment options focused on improving patient care."

Boston Scientific will demonstrate its Neuroform EZ Stent System at the 7th Annual Society of NeuroInterventional Surgery (SNIS) Meeting, July 26 – 30 in Carlsbad, California.

Latest stories

Related stories

Abbott to Acquire Cancer Test Maker for Around $21 Billion

In a recent move, Abbott has gone ahead and...

New Policy to Boost Medical Device Industry in China

Beijing has gone on to release a new policy...

US Lawmakers Push Access For AI-Powered Medical Devices

The US bipartisan legislation, which was introduced in the...

$622m Government Plan for South Korea Medical Device Sector

The South Korea Medical Device Sector is all set...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »